SUBSCRIBE
SUBSCRIBE
News   Business

Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111

October 25, 2006 | 
1 min read
RESEARCH TRIANGLE PARK, N.C., Oct. 24 /PRNewswire/ -- Viron Therapeutics, Inc. signed an agreement with Diosynth Biotechnology for process development, scale-up, and clinical manufacturing for their lead product candidate.
Alliances
MORE ON THIS TOPIC
change business management, businessman turn gear cog to manage change direction arrows, professional or expertise to manage company transformation or implement new process concept vector illustration
Manufacturing
Cell and Gene Therapy Manufacturing Market To Skyrocket to $146B by 2032
March 10, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Funding
AI-Focused Fund Breakout Raises $114M To Support Early-Stage Biotechs
March 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Cooperation concept. Vector of a businessman and a businesswoman connecting the bridge with a missing part
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
March 9, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Dashed line from pills isolated on white
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
 · 
2 min read
 · 
Tristan Manalac